Add like
Add dislike
Add to saved papers

A single nucleotide polymorphism in TLR4 is linked with the risk of HIV-1 infection.

INTRODUCTION: Toll-like receptors (TLRs) are pattern recognition receptors that play a role in innate immunity. Mounting evidence shows that single-nucleotide polymorphisms (SNPs) in TLRs link to various infectious diseases, including human immunodeficiency virus (HIV). We hypothesised links between two TLR4 SNPs (rs4986790 leading to Asp299Gly and rs4986791 leading to Thr399Ile) and HIV.

MATERIALS AND METHODS: We recruited 160 HIV-1 seropositive patients, who were further divided on disease severity based on CD4 count (stage I, II, and III), and 270 age and sex matched healthy HIV-1 seronegative (HSN) individuals. The subjects were genotyped for TLR4 gene polymorphism by PCR-RFLP.

RESULTS: TLR4 Asp299Gly heterozygous genotype (p=0.004) and the mutant allele G (p=0.002) were more frequent in patients with HIV-1 infection than healthy controls, and also in stage I of the infection (p=0.034) compared to different stages II, bout in stage I versus stage III. There was no link between the Thr399Ile polymorphism and HIV infection.

CONCLUSION: TLR4 (Asp299Gly) gene polymorphism is a risk factor in HIV-1 disease.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app